TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
UroMedical Väst AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
5,322
|
6,165
|
5,642 |
| Financial expenses |
872
|
38
|
475 |
| Earnings before taxes |
-329
|
989
|
-40 |
| EBITDA |
623
|
1,075
|
538 |
| Total assets |
1,518
|
1,973
|
2,770 |
| Current assets |
770
|
851
|
1,653 |
| Current liabilities |
631
|
650
|
1,451 |
| Equity capital |
814
|
1,248
|
1,244 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
22
|
22
|
22 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
53.6%
|
63.3%
|
44.9% |
| Turnover per employee |
242
|
280
|
256 |
| Profit as a percentage of turnover |
-6.2%
|
16.0%
|
-0.7% |
| Return on assets (ROA) |
35.8%
|
52.1%
|
15.7% |
| Current ratio |
122.0%
|
130.9%
|
113.9% |
| Return on equity (ROE) |
-40.4%
|
79.2%
|
-3.2% |
| Change turnover |
-633
|
506
|
220 |
| Change turnover % |
-11%
|
9%
|
4% |
| Chg. No. of employees |
0
|
0
|
3 |
| Chg. No. of employees % |
0%
|
0%
|
16% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.